Pacific Biosciences of California, Inc.
PACB
$2.41
$0.093.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.33% | 7.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.33% | 7.03% | |||
| Cost of Revenue | -10.42% | -17.39% | |||
| Gross Profit | 8.52% | 111.46% | |||
| SG&A Expenses | -14.03% | -9.94% | |||
| Depreciation & Amortization | 0.00% | -99.72% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.69% | -81.99% | |||
| Operating Income | 13.44% | 89.64% | |||
| Income Before Tax | 10.21% | 90.17% | |||
| Income Tax Expenses | 994.29% | 111.59% | |||
| Earnings from Continuing Operations | 9.37% | 90.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.37% | 90.16% | |||
| EBIT | 13.44% | 89.64% | |||
| EBITDA | 14.17% | 32.66% | |||
| EPS Basic | 9.59% | 90.27% | |||
| Normalized Basic EPS | 10.44% | 90.41% | |||
| EPS Diluted | 7.14% | 90.28% | |||
| Normalized Diluted EPS | 10.44% | 90.41% | |||
| Average Basic Shares Outstanding | 0.23% | 1.11% | |||
| Average Diluted Shares Outstanding | 0.23% | 1.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||